TLDR Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.
The document reports an observational study on 5 female patients who experienced frontal alopecia following repeated botulinum toxin type A (BTXA) injections for forehead wrinkles. The patients, with a mean age of 52.7 years, had been receiving BTXA injections at intervals ranging from 4 to 6 months. They all noticed a progressive recession of the hairline, with a mean distance of over 6 cm from the hairline to the glabella. Clinical and trichoscopic examinations revealed normal skin with signs of photoaging, no atrophy or scarring, and the presence of vellus and intermediate hair along the hairline. The study introduced the term 'botulin-induced frontal alopecia (BIFA)' to describe this phenomenon and differentiate it from other types of hair loss such as frontal fibrosing alopecia (FFA) and androgenetic alopecia. The authors suggest that dermatologists should be aware of the potential for frontal alopecia as a side effect of BTXA injections and call for further research to understand the prevalence and etiopathogenesis of BIFA.
166 citations,
April 2012 in “Journal of The American Academy of Dermatology” Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.
178 citations,
December 2011 in “Journal of Dermatological Case Reports” Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.
24 citations,
December 2010 in “Dermatologic surgery” Botulinum toxin type A injections are not effective for severe alopecia areata.
50 citations,
November 2010 in “Plastic and Reconstructive Surgery” Botox increased hair count in men with baldness and might work by improving scalp blood flow.
22 citations,
November 2007 in “Journal of Investigative Dermatology Symposium Proceedings” Hair growth and health are influenced by stress and hormones.
26 citations,
January 2018 in “Skin appendage disorders” Thallium, mercury, selenium, and colchicine strongly cause hair loss.
1 citations,
April 2018 in “Lasers in Surgery and Medicine” New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.
January 2016 in “Skin appendage disorders” The document discusses various nail and hair disorders and their treatments.
May 2023 in “Clinical, Cosmetic and Investigational Dermatology” More personalized and effective treatments for androgenetic alopecia are needed.
15 citations,
August 2020 in “BioMed Research International” BTA safely and effectively treats hair loss, and works better with FNS.